PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients

被引：0
|
作者：
Ming Chen
Jinlian Zhu
Xuedong Yang
Jianxin Yao
Yuqing Liu
Qiang Liu
机构：
[1] Changshu No.2 People’s Hospital,Department of Hematology
[2] Changshu No.2 People’s Hospital,Department of Oncology
[3] Changshu No.1 People’s Hospital,Department of Hematology
来源：
European Journal of Medical Research | / 27卷
关键词：
Relapsed/refractory multiple myeloma; T cell subtype; PD-1; LAG-3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PD-1 and LAG-3-positive T cells are associated with clinical outcomes of relapsed/refractory multiple myeloma patients
    Chen, Ming
    Zhu, Jinlian
    Yang, Xuedong
    Yao, Jianxin
    Liu, Yuqing
    Liu, Qiang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [2] PD-1 positive CD8+T cells are associated with better clinical outcomes in patients with the early stage of multiple sclerosis
    Chihara, Norio
    Koto, Shusuke
    Akatani, Ritsu
    Tsuji, Asato
    Katanazaka, Kimitaka
    Nishii, Shota
    Takeda, Ryosuke
    Shiroma, Kyoka
    Sekiguchi, Kenji
    Matsumoto, Riki
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 814 - 815
  • [3] Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas
    Hughes, Mitchell E.
    Jensen, Christopher
    Svoboda, Jakub
    Strelec, Lauren Elizabeth
    Youngman, Matthew R.
    Schuster, Stephen J.
    Landsburg, Daniel J.
    Nasta, Sunita Dwivedy
    Tsai, Donald Edward
    Mintzer, David Michael
    Gill, Jennifer
    Dorsey, Colleen
    Kennard, Kaitlin
    Chatburn, Elizabeth T.
    Rhodes, Joanna
    Isaac, Krista
    Walsh, Kristy
    Latorre, Tanya
    Piersanti, Kaley
    Bannister, Evan
    Timlin, Colleen
    Capozzi, Donna
    Mato, Anthony R.
    BLOOD, 2017, 130
  • [4] PD-1 and LAG-3 positive T cells are related with the prognosis of patients with chronic kidney disease
    Jiang, Hongwei
    Wu, Jing
    Zhang, Junlin
    EXPERIMENTAL CELL RESEARCH, 2024, 438 (01)
  • [5] PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells
    Bernabei, Luca
    Garfall, Alfred L.
    Melenhorst, J. Joseph
    Lacey, Simon F.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Gonzalez, Vanessa
    Plesa, Gabriela
    Young, Regina M.
    Waxman, Adam
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    Cohen, Adam D.
    BLOOD, 2018, 132
  • [6] Beta-Arrestin Isoforms Correlate with Clinical Outcomes in Patients with Multiple Myeloma and Alter PD-1/PD-L1 Expression in Murine T Cells
    Mathews, Parker
    Wu, Jian
    Wang, Xiaobei
    Neilson, Catherine
    Rein, Lindsay A. M.
    Kang, Yubin
    BLOOD, 2024, 144 : 6823 - 6824
  • [7] Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomes
    Richardson, Paul G.
    Harvey, R. Donald
    Laubach, Jacob P.
    Moreau, Philippe
    Lonial, Sagar
    San-Miguel, Jesus F.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 35 - 48
  • [8] Bone marrow PD-1 positive T cells reflect tumor mass and prognosis in multiple myeloma
    Chang, Yali
    Jiang, Yang
    Chen, Yun
    Xing, Xiangling
    Zhou, Yawei
    Sang, Tan
    Li, Jing
    Zhao, Aiping
    Zhang, Jingwen
    Zhao, Jun
    Liu, Yan
    Zheng, Chengyun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (01): : 304 - 313
  • [9] Predictors of Survival Outcomes in Phase 1 Relapsed or Refractory Multiple Myeloma Patients
    Barbee, Meagan S.
    Nooka, Ajay
    Kaufman, Jonathan L.
    Kim, Sungjin
    Chen, Zhengjia
    Heffner, Leonard T., Jr.
    Lonial, Sagar
    Harvey, R. Donald
    CANCER, 2015, 121 (06) : 853 - 862
  • [10] Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy
    Van Oekelen, Oliver
    Mouhieddine, Tarek
    Pan, Darren
    Metzger, Megan
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David
    Lancman, Guido
    Lagana, Alessandro
    Richard, Shambavi
    Sanchez, Larysa
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S38 - S38
12345